Metraipolis › archive › dc_7083079e98dd

First Report of Response to Tarlatamab in a Patient With Histologic-Transformed SCLC From ALK-Rearranged NSCLC: Case Report — Europe PMC PMID:41584719

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41584719
DOI
10.1016/j.jtocrr.2025.100941
License (as archived)
solo-consultazione
Archived
2026-11-07T16:46:10.751Z
SHA-256 of the archived text
67a5478665b5b5b761ef2312defdbad0a6220551864480cb56e2abcc8ab54ca1
Stable URL of this page
https://metraipolis.com/documento/dc_7083079e98dd

How to cite

First Report of Response to Tarlatamab in a Patient With Histologic-Transformed SCLC From ALK-Rearranged NSCLC: Case Report — Europe PMC PMID:41584719 — Europe PMC (en), https://europepmc.org/article/MED/41584719 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7083079e98dd (Metraipolis archive dc_7083079e98dd, sha256 67a5478665b5b5b761ef2312defdbad0a6220551864480cb56e2abcc8ab54ca1)
BibTeX
@misc{dc7083079e98dd,
  title = {First Report of Response to Tarlatamab in a Patient With Histologic-Transformed SCLC From ALK-Rearranged NSCLC: Case Report — Europe PMC PMID:41584719},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41584719},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7083079e98dd; sha256 67a5478665b5b5b761ef2312defdbad0a6220551864480cb56e2abcc8ab54ca1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41584719. Agents can read the archived copy with the MCP tool read_document.